Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 3Recruiting 2Terminated 1Active not recruiting 1

Sponsor Class

NIH 2OTHER 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

CNS 3Sarcoma 1Genitourinary 1Gastrointestinal 1

Conditions

Breast Neoplasms 668Neoplasms 585Colorectal Neoplasms 289Carcinoma, Non-Small-Cell Lung 287Prostatic Neoplasms 277Lung Neoplasms 219Melanoma 159Multiple Myeloma 149Neoplasm Metastasis 147Head and Neck Neoplasms 142Pancreatic Neoplasms 140Ovarian Neoplasms 129Carcinoma, Hepatocellular 127Leukemia, Myeloid, Acute 120Brain Neoplasms 114Squamous Cell Carcinoma of Head and Neck 110Colonic Neoplasms 109Uterine Cervical Neoplasms 107Recurrence 103Stomach Neoplasms 102Lymphoma 100Glioblastoma 91Lymphoma, Non-Hodgkin 82Precursor Cell Lymphoblastic Leukemia-Lymphoma 78Hematologic Neoplasms 78Urinary Bladder Neoplasms 77Lymphoma, Follicular 77Parkinson Disease 4, Autosomal Dominant Lewy Body 74Glioma 73Sarcoma 71

Interventions

Radiotherapy, Image-Guided 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Choroid Plexus Neoplasms × 1 year × Clear all
NCT03251989 2026-05-29

Rare CNS Tumors Outcomes &Risk

National Institutes of Health Clinical Center (CC)

Completed
326 enrolled
CNS

Brain Neoplasms, Ependymoma, Glioma, Medulloblastoma, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Neuroectodermal Tumors, Primitive, Rhabdoid Tumor

NCT02162732 2025-11-03

Molecular-Guided Therapy for Childhood Cancer

Milton S. Hershey Medical Center

Phase NA Completed
186 enrolled 12 charts
CNSGastrointestinalGenitourinarySarcoma

Carcinoma, Renal Cell, Craniopharyngioma, Ependymoma, Glioma, Carcinoma, Hepatocellular, Medulloblastoma, Meningioma, Neoplasms, Germ Cell and Embryonal, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma, Choroid Plexus Neoplasms, Sarcoma, Clear Cell, Neuroectodermal Tumors, Primitive, Rhabdoid Tumor

NCT03173950 2025-06-29

Immune Checkpoint Inhibitor Nivolumab in People With Recurrent Select Rare CNS Cancers

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
133 enrolled
CNS

Brain Neoplasms, Ependymoma, Medulloblastoma, Meningioma, Pinealoma, Spinal Cord Neoplasms, Choroid Plexus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡